Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.
BACKGROUND Amantadine is the most commonly used pharmacologic treatment for levodopa-related dyskinesias (LRD), yet its efficacy and tolerability vary substantially, challenging clinical decision-making. OBJECTIVE To explore clinical, demographic, and genetic factors associated with variability in amantadine treatmen...